Shane Lea
Corporate Officer/Principal en CELLECTAR BIOSCIENCES, INC. .
Fortuna: 119 589 $ al 30/04/2024
Perfil
Shane Lea is currently the Chief Commercial Officer at Cellectar Biosciences, Inc. Prior to this role, he served as the Senior Vice President-Hematology at TG Therapeutics, Inc. Mr. Lea completed his undergraduate degree at the University of Louisiana at Monroe.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/12/2023 | 39 599 ( 0.11% ) | 119 589 $ | 30/04/2024 |
Cargos activos de Shane Lea
| Empresas | Cargo | Inicio |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Corporate Officer/Principal | 21/11/2022 |
Antiguos cargos conocidos de Shane Lea.
| Empresas | Cargo | Fin |
|---|---|---|
| TG THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2022 |
Formación de Shane Lea.
| University of Louisiana at Monroe | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| TG THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Shane Lea
